Opthea Limited (OPT)
USD 3.41
(1.49%)
USD 3.41
(1.49%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 200.62 Million USD | 51789.02% |
| 2023 | 181.71 Thousand USD | 0.0% |
| 2022 | - USD | -100.0% |
| 2021 | 112.96 Thousand USD | -10.56% |
| 2020 | 126.3 Thousand USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2018 | - AUD | 0.0% |
| 2017 | - AUD | 0.0% |
| 2016 | - AUD | 0.0% |
| 2015 | - AUD | 0.0% |
| 2014 | - AUD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | -100.0% |
| 2005 | 2.88 Million USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| 1999 | - USD | 0.0% |
| 1998 | - USD | -100.0% |
| 1997 | 2143.79 USD | -73.46% |
| 1996 | 8078.22 USD | 0.0% |
| 1995 | - USD | 0.0% |
| 1994 | - USD | -100.0% |
| 1993 | 447.97 USD | -97.02% |
| 1992 | 15.02 Thousand USD | 155.54% |
| 1991 | 5880.59 USD | 0.0% |
| 1990 | - USD | 0.0% |
| 1989 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q4 | 200.62 Million USD | 0.0% |
| 2024 Q2 | 180.9 Million USD | 0.0% |
| 2024 FY | 200.62 Million USD | 110310.92% |
| 2023 FY | 181.71 Thousand USD | 0.0% |
| 2023 Q4 | 181.71 Thousand USD | 0.0% |
| 2023 Q2 | 210.65 Thousand USD | 0.0% |
| 2022 Q2 | 67.25 Thousand USD | 0.0% |
| 2022 FY | - USD | -100.0% |
| 2022 Q4 | - USD | 0.0% |
| 2021 Q2 | 158.3 Thousand USD | 0.0% |
| 2021 FY | 112.96 Thousand USD | -10.56% |
| 2021 Q4 | 112.96 Thousand USD | 0.0% |
| 2020 FY | 126.3 Thousand USD | 0.0% |
| 2020 Q4 | 126.3 Thousand USD | 0.0% |
| 2020 Q2 | 271.52 Thousand USD | 0.0% |
| 2019 Q2 | - USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2019 Q4 | - USD | 0.0% |
| 2018 FY | - AUD | 0.0% |
| 2018 Q4 | - AUD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q4 | - AUD | 0.0% |
| 2017 FY | - AUD | 0.0% |
| 2016 Q4 | - AUD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 FY | - AUD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 FY | - AUD | 0.0% |
| 2015 Q4 | - AUD | 0.0% |
| 2014 Q4 | - AUD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 FY | - AUD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 FY | - USD | -100.0% |
| 2005 Q4 | 2.88 Million USD | 0.0% |
| 2005 FY | 2.88 Million USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2002 Q4 | - USD | 0.0% |
| 2001 Q4 | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| 2000 Q4 | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| 1999 Q4 | - USD | 0.0% |
| 1998 FY | - USD | -100.0% |
| 1997 Q4 | 1615.57 USD | 0.0% |
| 1997 FY | 2143.79 USD | -73.46% |
| 1996 FY | 8078.22 USD | 0.0% |
| 1995 FY | - USD | 0.0% |
| 1994 FY | - USD | -100.0% |
| 1993 FY | 447.97 USD | -97.02% |
| 1992 FY | 15.02 Thousand USD | 155.54% |
| 1991 FY | 5880.59 USD | 0.0% |
| 1990 FY | - USD | 0.0% |
| 1989 FY | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Absci Corporation | 15.95 Million USD | -1157.309% |
| Adaptive Biotechnologies Corporation | 229.43 Million USD | 12.554% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | 92.521% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -66617.476% |
| Apollomics, Inc. | 4.66 Million USD | -4204.415% |
| 180 Life Sciences Corp. | 1.32 Million USD | -15098.356% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| Bicycle Therapeutics plc | 44.95 Million USD | -346.278% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -1446.153% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | -97.89% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -844.624% |
| Chimerix, Inc. | 2.14 Million USD | -9257.686% |
| CRISPR Therapeutics AG | 238.63 Million USD | 15.925% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | -3.849% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -3568.473% |
| Fortress Biotech, Inc. | 88.59 Million USD | -126.464% |
| Fortress Biotech, Inc. | 88.59 Million USD | -126.464% |
| Gritstone bio, Inc. | 104.77 Million USD | -91.485% |
| Allakos Inc. | 41.46 Million USD | -383.851% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -9040.264% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -364.774% |
| Cytokinetics, Incorporated | 755.77 Million USD | 73.454% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -1951.839% |
| Innoviva, Inc. | 449.07 Million USD | 55.324% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -363588.554% |
| NLS Pharmaceutics AG | 1.63 Million USD | -12180.293% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -2805.137% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -69167.613% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -33171.773% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -1348.583% |
| ImmuCell Corporation | 11.96 Million USD | -1576.194% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -6885.682% |
| Incyte Corporation | 38.28 Million USD | -424.013% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -564.131% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -122259.25% |
| Mustang Bio, Inc. | 2.49 Million USD | -7931.577% |
| MiMedx Group, Inc. | 48.09 Million USD | -317.116% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| MacroGenics, Inc. | 33.97 Million USD | -490.588% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Mereo BioPharma Group plc | 5.95 Million USD | -3270.779% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | -81.798% |
| Maravai LifeSciences Holdings, Inc. | 610.96 Million USD | 67.162% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -144.619% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -98731.917% |
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -141187.881% |
| NextCure, Inc. | 6.6 Million USD | -2937.529% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -11792.637% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Onconetix, Inc. | 9.88 Million USD | -1929.47% |
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -62990.815% |
| Ovid Therapeutics Inc. | 46 Million USD | -336.133% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -2520.065% |
| PDS Biotechnology Corporation | 23.85 Million USD | -741.154% |
| Precigen, Inc. | 7.09 Million USD | -2726.952% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| Prime Medicine, Inc. | 13.63 Million USD | -1371.641% |
| PureTech Health plc | 25.51 Million USD | -686.409% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -701.169% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 92.577% |
| Replimune Group, Inc. | 75.86 Million USD | -164.441% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Rigel Pharmaceuticals, Inc. | 60.57 Million USD | -231.185% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -44427.675% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | -128.132% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -426.529% |
| Solid Biosciences Inc. | 26.26 Million USD | -663.864% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -12170.874% |
| SciSparc Ltd. | 76 Thousand USD | -263885.251% |
| Sutro Biopharma, Inc. | 182.74 Million USD | -9.784% |
| TG Therapeutics, Inc. | 110.79 Million USD | -81.081% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -1944.52% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -35409.521% |
| Travere Therapeutics, Inc. | 404.78 Million USD | 50.436% |
| UroGen Pharma Ltd. | 100.21 Million USD | -100.2% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -340.846% |
| XOMA Corporation | 124.45 Million USD | -61.212% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -338.313% |
| AbCellera Biologics Inc. | 77.38 Million USD | -159.277% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -42137.64% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -860.671% |
| Precision BioSciences, Inc. | 31.26 Million USD | -541.643% |
| Dyadic International, Inc. | 136.92 Thousand USD | -146420.307% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -126880.247% |
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -3577.888% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -93651.771% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -1514.849% |
| IGM Biosciences, Inc. | 40.5 Million USD | -395.306% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -244.244% |
| Acelyrin, Inc. | 1.19 Million USD | -16703.081% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -3615.348% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -3154.319% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -32155.277% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -563.982% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | -223.204% |
| Senti Biosciences, Inc. | 37.66 Million USD | -432.652% |
| Mesoblast Limited | 118.92 Million USD | -68.705% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | -136.943% |
| ChromaDex Corporation | 3.27 Million USD | -6022.331% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | -92.575% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Seer, Inc. | 28.25 Million USD | -609.964% |
| Xeris Biopharma Holdings, Inc. | 229.19 Million USD | 12.462% |
| Novavax, Inc. | 280.63 Million USD | 28.509% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Fate Therapeutics, Inc. | 103.53 Million USD | -93.777% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | -217.616% |
| Celcuity Inc. | 37.44 Million USD | -435.778% |
| ContextLogic Inc. | 6 Million USD | -3243.813% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | -44.306% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -2958.832% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 96.539% |
| Amarin Corporation plc | 8.73 Million USD | -2196.312% |
| AnaptysBio, Inc. | 17.81 Million USD | -1026.242% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -3617.413% |
| Aptorum Group Limited | 3.36 Million USD | -5866.838% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -1731.39% |
| Arrowhead Pharmaceuticals, Inc. | 115.17 Million USD | -74.201% |
| Ardelyx, Inc. | 55.98 Million USD | -258.381% |
| Celularity Inc. | 65.41 Million USD | -206.692% |
| Omeros Corporation | 338.28 Million USD | 40.692% |
| Humacyte, Inc. | 58.1 Million USD | -245.281% |
| Immunocore Holdings plc | 84.03 Million USD | -138.753% |
| IO Biotech, Inc. | 2.49 Million USD | -7944.458% |
| GT Biopharma, Inc. | 58 Thousand USD | -345811.709% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -3898.182% |
| Summit Therapeutics Inc. | 106.09 Million USD | -89.096% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Pulmatrix, Inc. | 8.75 Million USD | -2191.329% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | -73.936% |
| Evogene Ltd. | 1.13 Million USD | -17529.946% |
| CorMedix Inc. | 667.63 Thousand USD | -29950.805% |
| BioLineRx Ltd. | 11.59 Million USD | -1630.901% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -9363.622% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -308559.678% |
| PTC Therapeutics, Inc. | 415.02 Million USD | 51.659% |
| scPharmaceuticals Inc. | 40.26 Million USD | -398.221% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -1754.069% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -132766.749% |
| NLS Pharmaceutics AG | 1.63 Million USD | -12180.293% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -670.375% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -57386.76% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -65679.931% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -2835.315% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -20519.609% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -464.273% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| Daré Bioscience, Inc. | 5.31 Million USD | -3672.533% |
| bluebird bio, Inc. | 330.32 Million USD | 39.263% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | 82.306% |
| DBV Technologies S.A. | 14.38 Million USD | -1295.096% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -1936.427% |
| Galecto, Inc. | 249 Thousand USD | -80473.812% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -3131.778% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -4252.979% |
| Inhibrx Biosciences, Inc. | 210.14 Million USD | 4.527% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -24717.948% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | 2.568% |
| ADMA Biologics, Inc. | 141.41 Million USD | -41.869% |
| Clene Inc. | 32.16 Million USD | -523.826% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -295.936% |
| Aptose Biosciences Inc. | 1 Million USD | -19768.053% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -2317700.266% |
| Soligenix, Inc. | 3.49 Million USD | -5641.173% |
| Century Therapeutics, Inc. | 48.17 Million USD | -316.493% |
| Kura Oncology, Inc. | 17.2 Million USD | -1066.446% |
| Surrozen, Inc. | 3.37 Million USD | -5837.52% |
| TScan Therapeutics, Inc. | 92.43 Million USD | -117.053% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -9231.572% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -1335.729% |
| Autolus Therapeutics plc | 52.96 Million USD | -278.781% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -379.48% |
| Caribou Biosciences, Inc. | 27.48 Million USD | -629.957% |
| GRI Bio, Inc. | 14 Thousand USD | -1432962.793% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -717.492% |
| INmune Bio, Inc. | 10.43 Million USD | -1822.284% |
| Heron Therapeutics, Inc. | 179.62 Million USD | -11.691% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -3296.424% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -245527.805% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -39953.422% |
| Jaguar Health, Inc. | 35.86 Million USD | -459.478% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -24164.407% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -287.501% |
| Clearside Biomedical, Inc. | 43 Million USD | -366.568% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -246.677% |
| Coherus BioSciences, Inc. | 480.84 Million USD | 58.276% |
| Verastem, Inc. | 41.55 Million USD | -382.78% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -1664.235% |
| Histogen Inc. | 4.62 Million USD | -4240.735% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -250.719% |
| Surrozen, Inc. | 3.37 Million USD | -5837.52% |
| Organovo Holdings, Inc. | 1.39 Million USD | -14292.309% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -939613.307% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | -137.184% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -95885.452% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -123503.067% |
| Kronos Bio, Inc. | 28.27 Million USD | -609.638% |
| Turnstone Biologics Corp. | 3.21 Million USD | -6142.339% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 247 Thousand USD | -81126.231% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | -194.048% |
| Aurinia Pharmaceuticals Inc. | 97.6 Million USD | -105.548% |
| Exelixis, Inc. | 189.94 Million USD | -5.625% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -555.35% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | -80.864% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -7101.321% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -249661.965% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -410435.689% |
| Avid Bioservices, Inc. | 207.83 Million USD | 3.467% |
| Insmed Incorporated | 1.2 Billion USD | 83.336% |
| MediWound Ltd. | 6.71 Million USD | -2889.551% |
| OmniAb, Inc. | 25.56 Million USD | -684.902% |
| Alector, Inc. | 38.91 Million USD | -415.517% |
| Seres Therapeutics, Inc. | 213.93 Million USD | 6.22% |
| Zai Lab Limited | 15.15 Million USD | -1224.195% |
| AlloVir, Inc. | 27.42 Million USD | -631.448% |
| Revance Therapeutics, Inc. | 478.43 Million USD | 58.066% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -1864.445% |
| Aura Biosciences, Inc. | 19.55 Million USD | -925.867% |
| Immunic, Inc. | 1.33 Million USD | -14939.64% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -532.26% |
| Veracyte, Inc. | 12.63 Million USD | -1488.51% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 68.888% |
| FibroGen, Inc. | 170.45 Million USD | -17.702% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -2109.325% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -5540.393% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -98290.372% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -542139.976% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -4635.161% |
| Fortrea Holdings Inc. | 1.67 Billion USD | 88.044% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -2641.954% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -7101.321% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -1289.011% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -22044.458% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -646.359% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -345.12% |
| Agenus Inc. | 350.24 Million USD | 42.718% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -14038.745% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -343.516% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -364.752% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -315.992% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | 76.361% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -19427.855% |
| C4 Therapeutics, Inc. | 70.97 Million USD | -182.671% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -1413376.053% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -51080.553% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -85466.569% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -52283.496% |
| Ainos, Inc. | 5.96 Million USD | -3264.248% |
| Pluri Inc. | 29.61 Million USD | -577.525% |
| Prothena Corporation plc | 11.83 Million USD | -1595.216% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -695.042% |
| Rallybio Corporation | 392 Thousand USD | -51080.814% |
| Kodiak Sciences Inc. | 181.63 Million USD | -10.459% |
| Cue Biopharma, Inc. | 14.69 Million USD | -1265.286% |
| MeiraGTx Holdings plc | 89.26 Million USD | -124.759% |
| Annexon, Inc. | 31.35 Million USD | -539.862% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -8466.558% |
| Moderna, Inc. | - USD | -Infinity% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -10727.242% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -4013.775% |
| Blueprint Medicines Corporation | 774.12 Million USD | 74.083% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -335.78% |
| Scholar Rock Holding Corporation | 61.81 Million USD | -224.548% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -524.662% |
| Sana Biotechnology, Inc. | 104.09 Million USD | -92.734% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -2800.517% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -535.948% |
| Nutriband Inc. | 241.28 Thousand USD | -83050.13% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -3569.815% |
| Vor Biopharma Inc. | 35.66 Million USD | -462.616% |
| Roivant Sciences Ltd. | 499.74 Million USD | 59.854% |
| Alkermes plc | 290.73 Million USD | 30.991% |
| ProKidney Corp. | 4.41 Million USD | -4446.313% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -16264.502% |
| Arcellx, Inc. | 97.62 Million USD | -105.51% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 88.469% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -415.49% |
| Galectin Therapeutics Inc. | 71.8 Million USD | -179.4% |
| Atai Life Sciences N.V. | 16.47 Million USD | -1117.703% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -8085.603% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -29622.784% |
| MediciNova, Inc. | 215.92 Thousand USD | -92815.532% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -7941.234% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -15809.939% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | -7.65% |
| Biomea Fusion, Inc. | 10.29 Million USD | -1848.609% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -5488.546% |
| Geron Corporation | 85.89 Million USD | -133.564% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -2090.032% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -1267.52% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -631.821% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -1536.717% |
| Royalty Pharma plc | 6.13 Billion USD | 96.73% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -1504.26% |
| Imunon, Inc. | 1.62 Million USD | -12248.56% |
| BioAtla, Inc. | 2.46 Million USD | -8055.642% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | -110.92% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -3517.54% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -493.05% |
| Structure Therapeutics Inc. | 5.45 Million USD | -3579.236% |
| 89bio, Inc. | 27.1 Million USD | -640.109% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -959.678% |
| aTyr Pharma, Inc. | 15.09 Million USD | -1229.108% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -1701.3% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -853.196% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -61349.645% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -12195.503% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 86.618% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | -89.158% |
| Liquidia Corporation | 3.5 Million USD | -5627.342% |
| Entera Bio Ltd. | 390 Thousand USD | -51343.28% |
| GH Research PLC | 343 Thousand USD | -58392.359% |
| Vericel Corporation | 88.14 Million USD | -127.617% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -2200.525% |
| Xencor, Inc. | 83.43 Million USD | -140.464% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -116090.019% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -245527.805% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -16288.215% |
| Vaxcyte, Inc. | 29.22 Million USD | -586.521% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -1740.125% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -2033.441% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -122259.25% |
| Portage Biotech Inc. | 47 Thousand USD | -426769.768% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -15809.939% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -8200.736% |
| OncoCyte Corporation | 2.86 Million USD | -6892.987% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -15342.297% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -133160.352% |
| Purple Biotech Ltd. | 351 Thousand USD | -57059.2% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -871.051% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -12037.253% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -15822.92% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -6251.022% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -34852.751% |
| United Therapeutics Corporation | 700 Million USD | 71.339% |
| HilleVax, Inc. | 51.19 Million USD | -291.907% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -198542.367% |
| Pharming Group N.V. | 171.54 Million USD | -16.954% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -9763.761% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -3735.381% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -840.55% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.73 Million USD | -650.351% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -1092.09% |
| Curis, Inc. | 2.79 Million USD | -7080.701% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -9290.76% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -1099.144% |
| BeiGene, Ltd. | 930.18 Million USD | 78.431% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -17483.593% |
| Erasca, Inc. | 55.85 Million USD | -259.17% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -7918.737% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -4220.172% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -7792.557% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -964.174% |
| Adicet Bio, Inc. | 20.92 Million USD | -858.845% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | 54.921% |
| Aditxt, Inc. | 18.21 Million USD | -1001.268% |
| Adagene Inc. | 22.3 Million USD | -799.404% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -1211.042% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -888.66% |
| Compugen Ltd. | 1.35 Million USD | -14750.392% |
| Generation Bio Co. | 97.89 Million USD | -104.945% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -60881.395% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -693.062% |
| Invivyd, Inc. | 2.16 Million USD | -9166.919% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -275.246% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -5693548.236% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -3519.498% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -318358.398% |
| 2seventy bio, Inc. | 256.67 Million USD | 21.835% |
| Instil Bio, Inc. | 86.05 Million USD | -133.143% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -3474.898% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -95215.57% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -41589.533% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -1066.65% |
| Vir Biotechnology, Inc. | 124.54 Million USD | -61.096% |
| Evaxion Biotech A/S | 10.86 Million USD | -1745.766% |
| Ocular Therapeutix, Inc. | 83.38 Million USD | -140.594% |
| Verve Therapeutics, Inc. | 74.9 Million USD | -167.837% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -2988.497% |
| Cingulate Inc. | 3.13 Million USD | -6299.44% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -489238.515% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -643.345% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -43045.977% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -892.279% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -12802.173% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -15822.92% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | -71.195% |
| ImmunityBio, Inc. | 883.67 Million USD | 77.296% |
| Korro Bio, Inc. | 33.2 Million USD | -504.176% |
| Kineta, Inc. | 1.31 Million USD | -15133.773% |
| BioVie Inc. | 6.11 Million USD | -3182.836% |
| Codexis, Inc. | 22.36 Million USD | -797.106% |
| Celularity Inc. | 65.41 Million USD | -206.692% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | -119.367% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -287.853% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -89346.63% |
| Cibus, Inc. | 24.62 Million USD | -714.869% |
| IN8bio, Inc. | 4.89 Million USD | -4000.323% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | -167.377% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -5040.374% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | 86.197% |
| Eyenovia, Inc. | 16.1 Million USD | -1145.541% |
| Puma Biotechnology, Inc. | 111.49 Million USD | -79.952% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -20268.405% |
| Elevation Oncology, Inc. | 30.13 Million USD | -565.723% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -1651.146% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -9235.914% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -656.719% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -6367.724% |
| Moolec Science SA | 2.64 Million USD | -7484.381% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -604.282% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -3078.026% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -8252.572% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -11476.964% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -173975.339% |
| Humacyte, Inc. | 58.1 Million USD | -245.281% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -1410.077% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 2.51 Million USD | -7864.621% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -14894.678% |
| Notable Labs, Ltd. | 2.04 Million USD | -9691.547% |
| Immunovant, Inc. | 138 Thousand USD | -145283.182% |
| Quantum-Si incorporated | 15.3 Million USD | -1211.042% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -50057.198% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -273.555% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -49683.819% |
| PepGen Inc. | 20.1 Million USD | -897.955% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.46 Million USD | -4395.421% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 886 Thousand USD | -22544.333% |
| XOMA Corporation | 124.45 Million USD | -61.212% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -73122.186% |
| Bionomics Limited | 239.61 Million USD | 16.271% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -1411.214% |
| uniQure N.V. | 138.4 Million USD | -44.954% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | -134.865% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -19340.774% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -20268.405% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -2109.325% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -11384.19% |
| Altimmune, Inc. | 671 Thousand USD | -29799.969% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -55322.318% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -1411.214% |
| Peak Bio, Inc. | 10.72 Million USD | -1771.222% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -369.132% |
| Benitec Biopharma Inc. | 284 Thousand USD | -70543.94% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -137.276% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -907.122% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 11.77 Million USD | -1603.275% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -907.122% |
| argenx SE | 20 Million USD | -903.144% |
| Immunome, Inc. | 1.65 Million USD | -12059.321% |
| Verona Pharma plc | 51.32 Million USD | -290.868% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -1951.839% |
| Shattuck Labs, Inc. | 4.2 Million USD | -4674.602% |
| CervoMed Inc. | - USD | -Infinity% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -4698.584% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -34195.52% |
| Moolec Science SA | 2.64 Million USD | -7484.381% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Design Therapeutics, Inc. | 3.05 Million USD | -6477.993% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -76475.874% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -1310.098% |
| Achilles Therapeutics plc | 4.61 Million USD | -4247.319% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -12802.173% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -24189.2% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | 46.316% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -566.563% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -5325.529% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -48244.287% |
| Beam Therapeutics Inc. | 173.17 Million USD | -15.855% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | 34.891% |
| AEON Biopharma, Inc. | 278 Thousand USD | -72068.63% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -2756.332% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -59789.191% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -187594.746% |
| NeurAxis, Inc. | 224.26 Thousand USD | -89362.584% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | -164.465% |
| Lumos Pharma, Inc. | 6.58 Million USD | -2946.755% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -1074.633% |
| Palisade Bio, Inc. | 369 Thousand USD | -54270.946% |
| Nutriband Inc. | 241.28 Thousand USD | -83050.13% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | -228.324% |
| Neurogene Inc. | 16.25 Million USD | -1134.259% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -602.949% |
| Athira Pharma, Inc. | 1.58 Million USD | -12557.968% |
| HCW Biologics Inc. | 6.45 Million USD | -3009.667% |
| XOMA Corporation | 124.45 Million USD | -61.212% |
| Nektar Therapeutics | 230.4 Million USD | 12.922% |
| Arvinas, Inc. | 3.4 Million USD | -5800.847% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -12195.503% |
| Merus N.V. | 12.16 Million USD | -1549.636% |
| Omega Therapeutics, Inc. | 128.42 Million USD | -56.219% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -1352.358% |
| Rezolute, Inc. | 2.22 Million USD | -8904.883% |
| Clene Inc. | 32.16 Million USD | -523.826% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -114510.313% |
| BeyondSpring Inc. | 3.99 Million USD | -4921.997% |
| Synlogic, Inc. | 17.27 Million USD | -1061.382% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -15332.984% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -573125.117% |
| Peak Bio, Inc. | 10.72 Million USD | -1771.222% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -286.397% |
| Krystal Biotech, Inc. | 8.09 Million USD | -2378.735% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | -13.339% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -2742.976% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -146779.651% |
| MannKind Corporation | 382.37 Million USD | 47.531% |
| Ikena Oncology, Inc. | 10.73 Million USD | -1768.4% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -48953.494% |
| Gossamer Bio, Inc. | 212.46 Million USD | 5.57% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -115203.903% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -2090.032% |
| Legend Biotech Corporation | 328.67 Million USD | 38.958% |
| Mural Oncology plc | 15 Million USD | -1236.723% |
| Disc Medicine, Inc. | 2.1 Million USD | -9449.205% |
| Champions Oncology, Inc. | 7.43 Million USD | -2600.253% |
| REGENXBIO Inc. | 89.29 Million USD | -124.693% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -23373.674% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -36181.252% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -3605.741% |
| Vaxart, Inc. | 26.51 Million USD | -656.69% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -1181.37% |
| Cellectis S.A. | 92.85 Million USD | -116.071% |
| Longeveron Inc. | 2.04 Million USD | -9729.926% |
| Repare Therapeutics Inc. | 3.41 Million USD | -5783.542% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | 85.637% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -330.608% |
| Revolution Medicines, Inc. | 87.94 Million USD | -128.132% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -115870.399% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -4975.355% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -63189.839% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -114545.023% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | 75.182% |
| Denali Therapeutics Inc. | 52.24 Million USD | -284.045% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -1292.727% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -14501.804% |
| Cingulate Inc. | 3.13 Million USD | -6299.44% |
| Passage Bio, Inc. | 26.29 Million USD | -663.021% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -2910.184% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -49073.723% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -22341.699% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -875.774% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -8085.185% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -6324.233% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -24638.445% |
| OmniAb, Inc. | 25.56 Million USD | -684.902% |
| Anew Medical, Inc. | 1.6 Million USD | -12400.236% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -578.193% |
| Lipocine Inc. | 17.16 Thousand USD | -1168656.792% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -1623.911% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -479.383% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -3296.424% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -250.915% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -98731.917% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -3784.391% |
| Ocugen, Inc. | 6.94 Million USD | -2790.488% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -1319.979% |
| Q32 Bio Inc. | 1.31 Million USD | -15122.215% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -29755.475% |
| Alumis Inc. Common Stock | 32.58 Million USD | -515.804% |
| Equillium, Inc. | 824 Thousand USD | -24248.154% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -2109.812% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -66597.071% |
| Dominari Holdings Inc. | 3.02 Million USD | -6525.786% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -212234.809% |
| vTv Therapeutics Inc. | 529 Thousand USD | -37826.047% |
| Bio-Techne Corporation | 419.53 Million USD | 52.179% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | -178.667% |
| Harmony Biosciences Holdings, Inc. | 193.56 Million USD | -3.649% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -1087.996% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -781.42% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -3211.799% |
| Nkarta, Inc. | 88.33 Million USD | -127.112% |
| BioCardia, Inc. | 1.31 Million USD | -15156.942% |
| Iterum Therapeutics plc | 19.5 Million USD | -928.391% |